No
evidence of ototoxicity Based
on preclinical animal data and 30 pediatric patients
with acute otitis media with tympanostomy tubes treated with ofloxacin otic and tested for audiometric
parameters. No change in hearing function occurred
in these patients.
Near neutral pH.
Minimal
systemic absorption4 plus
the convenience of once daily dosing for
otitis externa.
Sterile
Safe
whether or not the integrity of the
tympanic membrane is intact
*Cortisporin
is a registered trademark of Monarch
Pharmaceuticals. †CIPRODEX
is a registered trademark of Bayer AG. ††Cipro
is a registered trademark of Bayer Corporation.
FLOXIN® Otic and FLOXIN® Otic SINGLES® are only available by prescription.
A doctor can determine if FLOXIN®
Otic or FLOXIN®
Otic SINGLES®
is right for you.
This site is intended for use by residents of the United States.
Click here for Important Safety Information.
Based
on preclinical animal data and 30 pediatric patients
with acute otitis media with tympanostomy tubes treated with ofloxacin otic and tested for audiometric
parameters. No change in hearing function occurred
in these patients.
